Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26F6S6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,807
Award facts
- Contract value 100% obligated
- $6,807.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on November 18, 2025, for 90-count tablets of Jardiance 10 mg. This firm fixed-price delivery order has a ceiling value of $6,807.46 and is scheduled for completion by November 19, 2025. The contract does not include a set-aside designation, indicating it was awarded through open competition. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The delivery of Jardiance, a diabetes medication, supports the Defense Health Agency and other federal healthcare systems in fulfilling critical pharmaceutical needs for military personnel and beneficiaries. AmerisourceBergen's federal contracting activities demonstrate its role as a critical vendor in the military medical supply chain, with contract awards spanning a broad range of pharmaceutical products across multiple therapeutic domains. The company's extensive portfolio of federal contracts reflects its capacity to meet stringent procurement requirements and deliver essential medications that support the overall readiness and health maintenance objectives of the Department of Defense and related federal health programs.
Quick answers
Who was awarded contract SPE2DR26F6S6X?
SPE2DR26F6S6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F6S6X worth?
The government has obligated $6,807 on SPE2DR26F6S6X.
Is contract SPE2DR26F6S6X an order under another contract?
Yes. SPE2DR26F6S6X is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6S6X competed?
The extent of competition for SPE2DR26F6S6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award